Dr. Deborah Birx said the CDC math on SARS-CoV-2 deaths was, at least, 25% exaggerated, and no one blinked.
Remdesivir was eventually judged not only to be a "nothing burger," but a no-taste vegan patty that didn't satisfy hunger, as it failed field tests with patients.
The New England Journal of Medicine delivered a knockout blow to Gilead Sciences' attempt to breathe life into one of its failed drugs from the past.
Don't be surprised when the government scientists push a new candidate offering a symptom-mitigating drug for virus suffers.
The debate surrounding Hydroxychloroquine (HCQ)The debate of Remdesivir v. HCQ started on, or about, Friday, March 20, when Dr. Fauci stepped to the podium during a virus briefing to correct a favorable comment Trump made about HCQ. Fauci said: "You've got to be careful when you say 'fairly effective'. It (HCQ) was never done in a clinical trial…It was given to individuals and felt that maybe it worked."
Review of Part 3 Takeaways
